Correlation of ACR TI-RADS and Patient Outcomes in a Real-World Cohort Presenting for Thyroid Ultrasonography.
Thomas WilkinsonTom CawoodAnthony LimDavid RocheJasmine JiangBen ThomsonMichelle MaraisPenny HuntPublished in: Journal of the Endocrine Society (2023)
TI-RADS category is associated with malignancy rate and may alter clinical decision-making in a minority of patients; however, it is nondiscriminatory in the majority of nodules. In this study of unselected patients, nodules classified as TR5 and thus considered "highly suspicious" for cancer had only a modest risk of malignancy.